Medicare Enrolled
Dr. Maria Aloba, M.D.
Medical Oncology · El Paso, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Aloba from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aloba?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Aloba
Dr. Maria Aloba is a medical oncology specialist in El Paso, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Aloba performed 26,477 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Aloba received a total of $71,149 from 42 pharmaceutical and/or device companies across 126 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Aloba is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 33% volume in TX
$71,149 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗26,477
Medicare services
Top 33% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
9,600 | $0 | $5 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,393 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,866 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,673 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,515 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,332 | $10 | $64 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
861 | $6 | $31 |
| Anti-nausea injection (Aloxi/palonosetron) | 730 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 630 | $0 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
517 | $94 | $368 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
460 | $2 | $13 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
406 | $11 | $108 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
300 | $61 | $247 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
225 | $94 | $707 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
217 | $35 | $143 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
177 | $63 | $250 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
137 | $7 | $431 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
130 | $13 | $60 |
| Iron level test | 130 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
130 | $9 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
119 | $10 | $96 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
104 | $6 | $29 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 103 | $91 | $657 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
99 | $15 | $76 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
99 | $14 | $73 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
93 | $1,105 | $4,802 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
89 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
89 | $6 | $34 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
89 | $98 | $470 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
82 | $20 | $161 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 81 | $20 | $128 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
79 | $18 | $114 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
79 | $75 | $70 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
78 | $21 | $157 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
78 | $46 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
74 | $1 | $7 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
69 | $19 | $99 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
67 | $24 | $145 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
66 | $2 | $16 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
55 | $109 | $565 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
44 | $122 | $500 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
38 | $2 | $19 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
37 | $47 | $313 |
| PSA test (prostate cancer screening) | 35 | $18 | $94 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
31 | $28 | $686 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
31 | $35 | $821 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
31 | $148 | $1,067 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
28 | $65 | $560 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
20 | $38 | $135 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
17 | $28 | $247 |
| New patient office visit, complex (60-74 min) | 16 | $168 | $709 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
14 | $124 | $523 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
14 | $10 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.7% high complexity
67.4% medium
30.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$71,149
Total received (2018-2024)
Avg $10,164/year across 7 years
Top 18% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
126
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$198
2023
$10,809
2022
$7,629
2021
$16,277
2020
$2,169
2019
$29,358
2018
$4,709
Payments by company (2024)
Tactile Systems Technology Inc
$128
PFIZER INC.
$28
AstraZeneca Pharmaceuticals LP
$26
Regeneron Healthcare Solutions, Inc.
$17
Top 3 companies account for 91.4% of 2024 payments
All-time payments by company (2018-2024) ›
TESARO, Inc.
$8,511
Merck Sharp & Dohme Corporation
$8,383
Novartis Pharmaceuticals Corporation
$6,609
Novocure Inc.
$5,584
AstraZeneca Pharmaceuticals LP
$4,963
Rigel Pharmaceuticals, Inc.
$4,386
Keryx Biopharmaceuticals, Inc.
$3,980
Karyopharm Therapeutics Inc.
$3,832
G1 Therapeutics, Inc.
$3,000
CTI BioPharma Corp.
$2,975
Fresenius Kabi USA, LLC
$2,620
Epizyme, Inc.,
$2,500
Lilly USA, LLC
$2,000
GlaxoSmithKline, LLC.
$1,950
AbbVie Inc.
$1,800
JAZZ PHARMACEUTICALS INC.
$1,518
Seagen Inc.
$1,225
TG THERAPEUTICS, INC.
$1,125
Daiichi Sankyo Inc.
$935
Bayer HealthCare Pharmaceuticals Inc.
$900
EMD Serono, Inc.
$519
GENZYME CORPORATION
$296
Janssen Biotech, Inc.
$229
Sirtex Medical Inc
$198
Genentech USA, Inc.
$174
Alexion Pharmaceuticals, Inc.
$150
Tactile Systems Technology Inc
$128
Amgen Inc.
$124
AVEO Pharmaceuticals, Inc.
$120
Edwards Lifesciences Corporation
$96
E.R. Squibb & Sons, L.L.C.
$56
Pharming Healthcare, Inc.
$52
Astellas Pharma US Inc
$30
PFIZER INC.
$28
PUMA BIOTECHNOLOGY, INC.
$27
Gilead Sciences, Inc.
$25
Ipsen Biopharmaceuticals, Inc
$22
Regeneron Healthcare Solutions, Inc.
$17
Adaptive Biotechnologies Corporation
$17
NESTLE HEALTHCARE NUTRITION INC.
$16
Stemline Therapeutics Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$12
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Alecensa · Auryxia · CALQUENCE · COSELA · CYRAMZA · DARZALEX · ELITEK · ELZONRIS · ENHERTU · ERLEADA · Edwards SAPIEN 3 Transcatheter Heart Valve · FOTIVDA · Flexitouch Plus · IMBRUVICA · IMLYGIC · JEMPERLI · KEYTRUDA · LIBTAYO · LUMAKRAS · LYNPARZA · NERLYNX · ONIVYDE · OPDIVO · Optune · Perjeta · Pomalyst · SARCLISA · SIR-Spheres Microspheres · Soliris · Stimufend · TAGRISSO · TASIGNA · TAZVERIK · TEPMETKO · Tavalisse · Tepmetko · Trodelvy · UKONIQ · VENCLEXTA · VOWST · VYXEOS · Vitrakvi · Vonjo · XPOVIO · XTANDI · Xtandi · ZEJULA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
4
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
THE HOSPITALS OF PROVIDENCE - EAST CAMPUS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Aloba is a mixed practice specialist, with moderate Medicare volume, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Aloba experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Aloba performed 9,600 anti-nausea injection (fosaprepitant) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Aloba receive payments from pharmaceutical companies?
Yes. Dr. Aloba received a total of $71,149 from 42 companies across 126 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aloba's costs compare to other medical oncologists in El Paso?
Dr. Aloba's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aloba) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in El Paso
Browse medical oncologists in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
TESARO, Inc. Payments to Doctors
See all physicians who received payments from TESARO, Inc.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology